Table 2 TRACP 5b can distinguish between normal and BRONJ group with statistical significance
From: Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)
CTX | Non-BRONJ (6/18) | BRONJ (12/18) | P value |
|---|---|---|---|
Mean(pg/mL) | Mean(pg/mL) | ||
Baseline | 150.63 ± 50.69 | 171.36 ± 45.05 | 0.23 |
2 weeks | 126.24 ± 21.97 | 122.79 ± 24.58 | 0.87 |
4 weeks | 175.13 ± 48.28 | 172.71 ± 40.78 | 0.90 |
8 weeks | 91.69 ± 53.30 | 127.53 ± 38.00 | 0.12 |
TRACP 5b | Non-BRONJ (6/18) | BRONJ (12/18) | P value |
Mean(U/L) | Mean(U/L) | ||
Baseline | 1.49 ± 0.19 | 1.30 ± 0.07 | 0.00 |
2 weeks | 1.44 ± 0.18 | 1.33 ± 0.05 | 0.01 |
4 weeks | 1.42 ± 0.17 | 1.34 ± 0.04 | 0.07 |
8 weeks | 1.53 ± 0.16 | 1.37 ± 0.12 | 0.03 |